Overview
Cognex Corporation, based in the United States, is a prominent player in the industrial automation sector, specializing in machine vision products, software, and sensors that automate tasks that require visual recognition. Established in 1981 and headquartered in Naticock, Massachusetts, Cognex primarily serves manufacturing environments where precision is paramount, such as in electronic, automotive, pharmaceutical, and consumer products. Key projects and products include vision systems, vision sensors, and barcode readers which are integral for quality control, guiding assembly robots, and tracking, sorting, and identifying parts. Cognex’s innovations assist in improving manufacturing efficiency, ensuring product quality, and reducing production costs, thereby strengthening its market position in the expansive field of industrial automation.
AI+ Ask the community
Your question will be posted publicly for the community. AI-generated answers require a paid plan.
Thinking of good questions…
Basic Stats
The share price of Cognex Corporation as of 22 September 2026 is / share. This is a decrease of -1.78% from the prior week. The market cap (or net worth) of Cognex Corporation as of 22 September 2026 is MM.
The Factor Analysis chart (below right) shows a view of Cognex Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
Market & Dividend
| Market Cap | 10,006.39 MM |
| EV | 10,155.53 MM |
| Shares Out. | 168.22 MM |
| EPS (TTM) | 1.04 |
| Dividend Yield | 57.16 % |
| Ex-Dividend Date | 2026-08-20 |
Valuation & Profitability
| PE Ratio | 59.83 |
| Price/Book | 6.42 |
| ROA | 0.09 |
| ROE | 0.12 |
| ROIC | 0.10 |
| CROIC | 0.07 |
Shorts & Options
| Short Float | |
| Short Interest | |
| Days to Cover | |
| Borrow Rate | |
| Implied Volatility | |
| Put/Call OI Ratio |
Risk & Price
| Beta | 1.93 |
| Volatility (1 yr) | 0.60 |
| Sharpe Ratio (1 yr) | 0.39 |
| Price Change (1 yr) (1Y) | 28.64 % |
| Risk Free Rate | 4.96 % |
Fintel Scores
| Quality Score | 63.11 |
| Value Score | 49.05 |
| Momentum Score | 61.57 |
| Growth | 73.41 |
| Piotroski F-SCORE | 8.00 |
Ownership
| Fund Sentiment | 75.50 |
| Insider Sentiment | |
| Officer Sentiment | |
| Analyst Sentiment | 71.54 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Cognex Corporation is US$80.30. The forecasts range from a low of to a high of US$95.77. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Cognex Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-02 | Truist Securities | Buy | Buy | Maintains |
| 2024-05-07 | HSBC | Hold | Buy | Upgrade |
| 2024-05-07 | Truist Securities | Buy | Buy | Reiterate |
| 2024-05-06 | Goldman Sachs | Sell | Sell | Maintains |
| 2024-05-03 | Bernstein | Outperform | Outperform | Maintains |
| 2024-05-03 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-03 | Needham | Buy | Buy | Maintains |
| 2024-05-03 | Baird | Neutral | Neutral | Maintains |
| 2024-04-08 | Citigroup | Neutral | Neutral | Maintains |
| 2024-03-19 | UBS | Neutral | Buy | Upgrade |
| 2024-03-14 | Truist Securities | Buy | Initiate | |
| 2023-11-06 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-11-02 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-01 | Needham | Buy | Buy | Maintains |
| 2023-10-10 | Goldman Sachs | Sell | Sell | Maintains |
| 2023-10-03 | Keybanc | Sector Weight | Initiate | |
| 2023-09-01 | Needham | Buy | Buy | Reiterate |
| 2023-08-30 | Citigroup | Neutral | Initiate | |
| 2023-08-07 | Credit Suisse | Neutral | Neutral | Maintains |
| 2023-08-04 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2023-08-03 | Needham | Buy | Maintains | |
| 2023-07-13 | Credit Suisse | Neutral | Neutral | Maintains |
| 2023-06-20 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2023-05-09 | Credit Suisse | Neutral | Maintains | |
| 2023-05-05 | Morgan Stanley | Underweight | Maintains | |
| 2023-05-05 | Needham | Buy | Reiterate | |
| 2023-02-23 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2023-02-21 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2023-02-17 | Needham | Buy | Maintains | |
| 2023-02-01 | Northcoast Research | Buy | Neutral | Downgrade |
| 2023-01-17 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2022-12-13 | Credit Suisse | Underperform | Initiate | |
| 2022-11-22 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2022-11-07 | Raymond James | Strong Buy | Maintains | |
| 2022-11-04 | Needham | Buy | Maintains | |
| 2022-10-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-20 | Needham | Buy | Maintains | |
| 2022-08-12 | JP Morgan | Neutral | Underweight | Downgrade |
| 2022-08-04 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-08-03 | Cowen & Co. | Outperform | Maintains | |
| 2022-08-03 | Raymond James | Strong Buy | Maintains | |
| 2022-08-03 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2022-08-03 | Bernstein | Market Perform | Outperform | Upgrade |
| 2022-08-03 | Needham | Buy | Maintains | |
| 2022-08-01 | Needham | Buy | Maintains | |
| 2022-06-23 | Goldman Sachs | Sell | Maintains | |
| 2022-06-09 | Raymond James | Strong Buy | Maintains | |
| 2022-05-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-26 | UBS | Neutral | Maintains | |
| 2022-05-09 | Raymond James | Strong Buy | Maintains | |
| 2022-05-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-06 | Needham | Buy | Maintains | |
| 2022-04-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-07 | Goldman Sachs | Sell | Maintains | |
| 2022-02-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-18 | JP Morgan | Underweight | Neutral | Upgrade |
| 2022-01-25 | Daiwa Capital | Neutral | Outperform | Upgrade |
| 2022-01-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-12 | Cowen & Co. | Outperform | Maintains | |
| 2021-11-12 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2021-11-08 | Northcoast Research | Neutral | Buy | Upgrade |
| 2021-11-08 | Needham | Hold | Buy | Upgrade |
| 2021-11-08 | Raymond James | Strong Buy | Maintains | |
| 2021-10-07 | Morgan Stanley | Underweight | Maintains | |
| 2021-05-19 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2021-05-07 | Morgan Stanley | Underweight | Maintains | |
| 2021-02-12 | Cowen & Co. | Outperform | Maintains | |
| 2021-02-12 | Morgan Stanley | Underweight | Maintains | |
| 2021-02-12 | Raymond James | Outperform | Maintains | |
| 2021-01-20 | Morgan Stanley | Underweight | Maintains | |
| 2021-01-14 | HSBC | Hold | Buy | Upgrade |
| 2020-10-29 | Morgan Stanley | Underweight | Maintains | |
| 2020-10-16 | Stephens & Co. | Overweight | Initiate | |
| 2020-09-04 | Daiwa Capital | Outperform | Neutral | Downgrade |
| 2020-07-31 | Morgan Stanley | Underweight | Maintains | |
| 2020-06-02 | Baird | Neutral | Underperform | Downgrade |
| 2020-05-26 | HSBC | Hold | Initiate | |
| 2020-05-08 | UBS | Neutral | Maintains | |
| 2020-04-28 | Baird | Neutral | Maintains | |
| 2020-04-28 | Morgan Stanley | Underweight | Maintains | |
| 2020-04-28 | Raymond James | Outperform | Maintains | |
| 2020-04-17 | JP Morgan | Underweight | Maintains | |
| 2020-03-23 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2020-03-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-02-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-12-12 | UBS | Neutral | Initiate | |
| 2019-09-23 | DA Davidson | Neutral | Maintains | |
| 2019-09-23 | Baird | Neutral | Maintains | |
| 2019-07-16 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2019-07-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-04-30 | Bernstein | Outperform | Market Perform | Downgrade |
| 2019-04-30 | Needham | Buy | Hold | Downgrade |
| 2019-04-17 | Gordon Haskett | Hold | Initiate | |
| 2018-10-30 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-02 | DA Davidson | Neutral | Initiate | |
| 2018-08-24 | Northcoast Research | Buy | Neutral | Downgrade |
| 2018-08-21 | Morgan Stanley | Equal-Weight | Initiate | |
| 2018-08-01 | Bernstein | Market Perform | Outperform | Upgrade |
| 2018-05-07 | JP Morgan | Neutral | Underweight | Downgrade |
| 2018-05-01 | Raymond James | Market Perform | Outperform | Upgrade |
| 2018-05-01 | Baird | Neutral | Neutral | Maintains |
| 2018-05-01 | JP Morgan | Neutral | Neutral | Maintains |
| 2018-04-10 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-04-03 | JP Morgan | Underweight | Neutral | Upgrade |
| 2018-02-15 | Canaccord Genuity | Hold | Hold | Maintains |
| 2017-12-08 | Daiwa Capital | Outperform | Buy | Upgrade |
| 2017-10-31 | Canaccord Genuity | Hold | Maintains | |
| 2017-10-31 | Baird | Neutral | Maintains | |
| 2017-07-11 | Wolfe Research | Peer Perform | Initiate | |
| 2017-04-03 | Goldman Sachs | Buy | Initiate | |
| 2017-01-26 | JP Morgan | Neutral | Initiate | |
| 2016-12-08 | Deutsche Bank | Buy | Initiate | |
| 2016-11-07 | CLSA | Underperform | Outperform | Upgrade |
| 2016-10-25 | Stephens & Co. | Equal-Weight | Initiate | |
| 2016-08-02 | Canaccord Genuity | Hold | Maintains | |
| 2016-08-02 | CLSA | Underperform | Maintains | |
| 2016-06-14 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2016-06-06 | Bernstein | Market Perform | Initiate | |
| 2016-05-11 | FBR Capital | Market Perform | Initiate | |
| 2016-04-01 | Canaccord Genuity | Buy | Maintains | |
| 2016-03-24 | CSLA | Outperform | Underperform | Downgrade |
| 2016-03-11 | Raymond James | Outperform | Market Perform | Downgrade |
| 2016-01-22 | Raymond James | Outperform | Initiate | |
| 2015-11-18 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2015-11-11 | FBR Capital | Market Perform | Initiate | |
| 2015-11-03 | Canaccord Genuity | Hold | Maintains | |
| 2015-11-03 | CLSA | Buy | Outperform | Downgrade |
| 2015-10-12 | Cowen & Co. | Outperform | Initiate | |
| 2015-09-17 | Nomura | Buy | Initiate | |
| 2015-08-04 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2015-04-23 | Oppenheimer | Outperform | Perform | Downgrade |
| 2015-03-18 | Northcoast Research | Buy | Initiate | |
| 2013-12-18 | BB&T Capital | Buy | Initiate | |
| 2013-09-12 | Baird | Outperform | Neutral | Downgrade |
| 2013-09-11 | PiperJaffray | Underweight | Neutral | Upgrade |
| 2013-07-08 | CLSA | Buy | Initiate | |
| 2012-09-25 | PiperJaffray | Neutral | Underweight | Downgrade |
| 2024-07-23 | Vertical Research | Buy | Initiate | |
| 2024-08-05 | DA Davidson | Neutral | Neutral | Maintains |
| 2024-08-05 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2025-05-06 | Goldman Sachs | Sell | Sell | Maintains |
| 2025-03-12 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-11-05 | Truist Securities | Buy | Hold | Downgrade |
| 2025-05-02 | UBS | Buy | Buy | Maintains |
| 2024-08-02 | Truist Securities | Buy | Buy | Maintains |
| 2024-08-02 | Needham | Buy | Buy | Maintains |
| 2024-11-01 | Needham | Buy | Buy | Maintains |
| 2025-02-14 | Needham | Buy | Buy | Maintains |
| 2025-08-04 | DA Davidson | Neutral | Neutral | Maintains |
| 2025-02-14 | Truist Securities | Hold | Hold | Reiterate |
| 2024-08-05 | Baird | Neutral | Neutral | Maintains |
| 2024-07-29 | Needham | Buy | Buy | Maintains |
| 2024-08-02 | Goldman Sachs | Sell | Sell | Maintains |
| 2024-12-19 | Cantor Fitzgerald | Overweight | Initiate | |
| 2024-12-19 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-16 | Truist Securities | Hold | Hold | Maintains |
| 2025-04-14 | Citigroup | Neutral | Neutral | Maintains |
| 2025-01-13 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-01 | UBS | Buy | Buy | Maintains |
| 2025-08-01 | Keybanc | Sector Weight | Overweight | Upgrade |
| 2025-07-31 | Needham | Buy | Buy | Maintains |
| 2025-02-18 | Goldman Sachs | Sell | Sell | Maintains |
| 2025-02-18 | UBS | Buy | Buy | Maintains |
| 2025-02-18 | Baird | Neutral | Neutral | Maintains |
| 2025-01-02 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2025-04-08 | Truist Securities | Hold | Hold | Maintains |
| 2025-05-05 | DA Davidson | Neutral | Neutral | Maintains |
| 2025-05-01 | Needham | Buy | Buy | Maintains |
| 2025-09-16 | Goldman Sachs | Sell | Sell | Maintains |
| 2025-06-12 | Goldman Sachs | Sell | Sell | Maintains |
| 2025-11-03 | DA Davidson | Neutral | Neutral | Maintains |
| 2025-06-16 | DA Davidson | Neutral | Neutral | Maintains |
| 2025-06-16 | Baird | Neutral | Neutral | Maintains |
| 2025-10-08 | Truist Securities | Hold | Hold | Maintains |
| 2025-10-08 | Barclays | Overweight | Initiate | |
| 2025-07-14 | Citigroup | Neutral | Neutral | Maintains |
| 2025-06-11 | Needham | Buy | Buy | Maintains |
| 2025-12-03 | JP Morgan | Neutral | Underweight | Downgrade |
| 2026-01-12 | Barclays | Overweight | Overweight | Maintains |
| 2025-09-15 | JP Morgan | Neutral | Initiate | |
| 2025-10-31 | Barclays | Overweight | Overweight | Maintains |
| 2026-02-12 | Needham | Buy | Buy | Maintains |
| 2026-02-13 | Barclays | Overweight | Overweight | Maintains |
| 2026-02-13 | Keybanc | Overweight | Overweight | Maintains |
| 2025-12-18 | Truist Securities | Hold | Hold | Maintains |
| 2025-12-16 | Goldman Sachs | Sell | Buy | Upgrade |
| 2026-02-17 | Goldman Sachs | Buy | Buy | Maintains |
| 2026-02-17 | DA Davidson | Neutral | Neutral | Maintains |
| 2026-02-17 | HSBC | Hold | Buy | Upgrade |
| 2025-10-31 | Needham | Buy | Buy | Maintains |
| 2026-03-09 | JP Morgan | Underweight | Neutral | Upgrade |
| 2026-04-20 | Truist Securities | Hold | Hold | Maintains |
| 2026-05-26 | JP Morgan | Neutral | Overweight | Upgrade |
| 2026-03-16 | Barclays | Overweight | Overweight | Maintains |
| 2026-05-11 | Goldman Sachs | Buy | Buy | Maintains |
| 2026-05-11 | Barclays | Overweight | Overweight | Maintains |
| 2026-05-14 | DA Davidson | Neutral | Neutral | Maintains |
| 2026-05-08 | Citigroup | Neutral | Neutral | Maintains |
| 2026-05-08 | Truist Securities | Hold | Hold | Maintains |
| 2026-05-08 | JP Morgan | Neutral | Neutral | Maintains |
| 2026-05-08 | Needham | Buy | Buy | Maintains |
| 2026-05-07 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2026-07-13 | Citigroup | Neutral | Neutral | Maintains |
| 2026-07-02 | Truist Securities | Hold | Hold | Maintains |
| 2026-08-07 | Truist Securities | Hold | Hold | Maintains |
| 2026-08-07 | Needham | Buy | Buy | Maintains |
| 2026-08-07 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2026-08-10 | Barclays | Overweight | Overweight | Maintains |
| 2026-08-10 | DA Davidson | Neutral | Neutral | Maintains |
| 2026-08-10 | HSBC | Buy | Hold | Downgrade |
| 2026-08-07 | Citigroup | Neutral | Neutral | Maintains |
| 2026-09-15 | Needham | Buy | Buy | Reiterate |
Latest Headlines
HSBC Downgrades Cognex (LSE:0I14)
by George Maybach
fintel.io
- 08-13
HSBC has downgraded its outlook for Cognex (LSE:0I14) from Buy to Hold, Fintel reports on August 10, 2026.
JP Morgan Upgrades Cognex (LSE:0I14)
by George Maybach
fintel.io
- 05-28
Fintel reports that on May 26, 2026, JP Morgan upgraded their outlook for Cognex (LSE:0I14) from Neutral to Overweight.
